Cargando…

Targeting HPV16 DNA using CRISPR/Cas inhibits anal cancer growth in vivo

AIM: The goal of this study was to determine if a single AAV vector, encoding Cas9 and guide RNAs specific for the HPV16 E6 and E7 genes, could inhibit the growth of an HPV16-induced tumor in vivo. MATERIALS & METHODS: We grew HPV16(+), patient-derived anal cancer explants in immunodeficient mic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, David S, Kornepati, Anand VR, Glover, Wayne, Kennedy, Edward M, Cullen, Bryan R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2018
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136077/ https://www.ncbi.nlm.nih.gov/pubmed/30245733 http://dx.doi.org/10.2217/fvl-2018-0010

Ejemplares similares

Expression of CRISPR/Cas single guide RNAs using small tRNA promoters
por: Mefferd, Adam L., et al.
Publicado: (2015)

Partial reconstitution of the RNAi response in human cells using Drosophila gene products
por: Kennedy, Edward M., et al.
Publicado: (2017)

Genotyping of high-risk anal human papillomavirus (HPV): ion torrent-next generation sequencing vs. linear array
por: Nowak, Rebecca G., et al.
Publicado: (2017)

Significance of HPV16 Viral Load Testing in Anal Cancer
por: Małusecka, Ewa, et al.
Publicado: (2020)

Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells
por: Hu, Zheng, et al.
Publicado: (2014)

The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
por: Zhu, Weijun, et al.
Publicado: (2015)

CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting
por: Courtney, D G, et al.
Publicado: (2016)

HPV status and HPV16 viral load in anal cancer and its association with clinical outcome
por: Guerendiain, Daniel, et al.
Publicado: (2022)

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
por: Beachler, Daniel C., et al.
Publicado: (2016)

Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications
por: Friedland, Ari E., et al.
Publicado: (2015)

Heterochromatin delays CRISPR-Cas9 mutagenesis but does not influence the outcome of mutagenic DNA repair
por: Kallimasioti-Pazi, Eirini M., et al.
Publicado: (2018)

Anal HIV DNA is associated with high-risk HPV genotypes in anal cytology specimens obtained for anal neoplasia screening
por: Shiramizu, Bruce, et al.
Publicado: (2012)

Mapping HPV 16 Sub-Lineages in Anal Cancer and Implications for Disease Outcomes
por: Guerendiain, Daniel, et al.
Publicado: (2022)

CRISPR/Cas9-loaded stealth liposomes effectively cleared established HPV16-driven tumours in syngeneic mice
por: Jubair, Luqman, et al.
Publicado: (2021)

Exploring the ecological function of CRISPR-Cas virus defense
por: Lundgren, Magnus
Publicado: (2016)

Circulating HPV16 DNA in Blood Plasma as Prognosticator and Early Indicator of Cancer Recurrence in Radio-Chemotherapy for Anal Cancer
por: Mazurek, Agnieszka M., et al.
Publicado: (2023)

The Prognostic Value of HPV Status and p16 Expression in Patients with Carcinoma of the Anal Canal
por: Roldán Urgoiti, Gloria B., et al.
Publicado: (2014)

CDetection: CRISPR-Cas12b-based DNA detection with sub-attomolar sensitivity and single-base specificity
por: Teng, Fei, et al.
Publicado: (2019)

Characterisation of anal intraepithelial neoplasia and anal cancer in HIV‐positive men by immunohistochemical markers p16, Ki‐67, HPV‐E4 and DNA methylation markers
por: van der Zee, Ramon P., et al.
Publicado: (2021)

Minimal genome-wide human CRISPR-Cas9 library
por: Gonçalves, Emanuel, et al.
Publicado: (2021)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

DNA high-risk HPV, mRNA HPV and P16 tests for diagnosis of anal cancer and precursor lesions: a systematic review and meta-analysis
por: Macedo, Ana Cristina, et al.
Publicado: (2023)

CRISPR-Cas immunity, DNA repair and genome stability
por: Cubbon, Andrew, et al.
Publicado: (2018)

High prevalence of anal high‐risk HPV infection among transwomen: estimates from a Brazilian RDS study
por: Jalil, Emilia M, et al.
Publicado: (2021)

Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence
por: Namujju, Proscovia B, et al.
Publicado: (2011)

In Vitro Pre-validation of Gene Editing by CRISPR/Cas9 Ribonucleoprotein
por: Mehravar, Maryam, et al.
Publicado: (2019)

Analysis of E2 gene integrity in HPV16 and HPV58 viruses isolated from women with cervical pathology
por: González-Losa, María del R, et al.
Publicado: (2016)

DNA Methylation Profiling across the Spectrum of HPV-Associated Anal Squamous Neoplasia
por: Hernandez, Jonathan M., et al.
Publicado: (2012)

Gene targeting using the Agrobacterium tumefaciens-mediated CRISPR-Cas system in rice
por: Xu, Rongfang, et al.
Publicado: (2014)

CRISPR/Cas9-mediated target validation of the splicing inhibitor Pladienolide B
por: Aouida, Mustapha, et al.
Publicado: (2016)

Site-specific recruitment of epigenetic factors with a modular CRISPR/Cas system
por: Anton, Tobias, et al.
Publicado: (2017)

Improving the genome editing efficiency of CRISPR/Cas9 in Arabidopsis and Medicago truncatula
por: Wolabu, Tezera W., et al.
Publicado: (2020)

Genetic modification of the protozoan Eimeria tenella using the CRISPR/Cas9 system
por: Tang, Xinming, et al.
Publicado: (2020)

What did CRISPR-Cas9 accomplish in its first 10 years?
por: Khlidj, Yehya
Publicado: (2023)

The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results
por: Volpini, Lays Paula Bondi, et al.
Publicado: (2017)

Detection of CRISPR-dCas9 on DNA with Solid-State Nanopores
por: Yang, Wayne, et al.
Publicado: (2018)

Inhibition of CRISPR-Cas12a DNA targeting by nucleosomes and chromatin
por: Strohkendl, Isabel, et al.
Publicado: (2021)

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
por: Wilbie, Danny, et al.
Publicado: (2019)

Structural and functional characterization of Cas2 of CRISPR-Cas subtype I-C lacking the CRISPR component
por: Anand, Vineet, et al.
Publicado: (2022)

Quorum Sensing Controls Adaptive Immunity through the Regulation of Multiple CRISPR-Cas Systems
por: Patterson, Adrian G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g9v73t6ri7uth5b08ch1mpailg